- Report
- February 2024
- 200 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- March 2021
- 112 Pages
Global
From €4562EUR$4,750USD£3,928GBP
- Report
- March 2022
Global
From €4658EUR$4,850USD£4,010GBP
- Report
- March 2021
United States, Europe, ... United States, Europe, Japan
From €912EUR$950USD£786GBP
- Report
- February 2020
Europe, Japan, United States Europe, Japan, United States
From €912EUR$950USD£786GBP
Amikacin is an aminoglycoside antibiotic used to treat a wide range of bacterial infections. It is effective against both gram-positive and gram-negative bacteria, and is often used in combination with other antibiotics. Amikacin is typically administered intravenously or intramuscularly, and is available in both generic and branded formulations. It is commonly used to treat infections of the urinary tract, respiratory tract, and skin and soft tissue.
Amikacin is a widely used antibiotic, and is available in many countries around the world. It is often used in combination with other antibiotics, and is generally well tolerated with few side effects. It is also relatively inexpensive, making it an attractive option for treating bacterial infections.
Some companies in the Amikacin market include Pfizer, Merck, Sanofi, GlaxoSmithKline, and Novartis. Show Less Read more